AbbVie Inc. (ABBV) Q1 2019 Earnings Results

AbbVie Beats on EPS, Stock Up 0.85%

AbbVie's earnings report shows that the company exceeded expectations on EPS, which positively influenced the stock price, resulting in a 0.85% increase. The lack of revenue data leaves some uncertainty, but management's positive tone suggests they are on the right track with their ongoing projects. Investors may remain cautiously optimistic about the company's future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.14	N/A	+3.35%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They noted solid progress in their product offerings.

Management highlighted strong performance in key therapeutic areas.

They emphasized ongoing commitment to pipeline development.

AbbVie Beats on EPS, Stock Up 0.85%

Key numbers

Management commentary

AbbVie Inc.

More earnings this week

AbbVie Beats on EPS, Stock Up 0.85%

Key numbers

Management commentary